iFR Assessment of Intermediate Aortic Stenosis Lesions Consolidates

Once a big void that prevented us from effectively assessing functional compromise, intermediate aortic stenosis has made us treat many lesions “just in case”, to save us what would be a complicated procedure, had a valve been placed. Auspiciously, some light has been shed by several, most welcome, studies simultaneously published in J Am Coll Cardiol Intv.

iFR en lesiones no culpables: el momento de la medición parece cambiar la historiaThis study looked at 95 consecutive patients with severe aortic stenosis and intermediate coronary lesions in 116 vessels. It compared invasive iFR with FFR values and non-invasive adenosine stress myocardial perfusion imaging.  

 

Mean iFR was 0.86 (0.76 to 0.93) and FFR was 0.84 (0.76 to 0.91). According to authors, iFR values showed good correlation with FFR values. However, these figures have different clinical implications, seeing as they have different cutoff values. The authors adjusted iFR cut off value to 0.82, but considered standard an FFR cutoff value of ≤0.75. The latter used to be the original value, the one in the DEFER study, one that has been replaced by 0.8 since the FAME trials.


Read also: Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients.


FFR and iFR values also correlated well with perfusion values.

 

Conclusion

According to this study, iFR, FFR, and stress adenosine prefusion values correlate well in patients with severe aortic stenosis. However, this could be misleading: there was no assessment after procedure to check whether values had changed. In this context, rather than changing cutoff index values, it would be easier to measure with iFR alone, since it is not affected by stenosis, compared to FFR which tends to underestimate severity.

 

Original title: Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients with Severe Aortic Valve Stenosis. Comparison With Myocardial Perfusion Scintigraphy.

Reference: Futoshi Yamanaka et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....